Company: CGC
Filing Date: 2025-08-29
Form Type: 424B5
Source: 0001104659-25-085662
Chunk: 6

Company: Canopy Growth Corp
Filing Date: 2025-08-29
Form: 424B5
Chunk 6
---
 units outstanding under the Omnibus Incentive Plan;

<div align='center'>S-3</div>

TABLE OF CONTENTS

•

up to 5,462 Common Shares issuable upon the vesting of performance share units outstanding under the Omnibus Incentive Plan;

•

up to 31,199,061 Common Shares available for future issuance under the Omnibus Incentive Plan, based on the Common Shares outstanding as of August 28, 2025 (the Omnibus Incentive Plan provides that the aggregate number of Common Shares reserved for issuance for awards granted under the Omnibus Incentive Plan and under all other equity plans of the Company shall not exceed 10% of the Company’s total issued and outstanding Common Shares from time to time);

•

up to 13,719,884 Common Shares issuable upon exercise of common share purchase warrants (“Warrants”) with a weighted average exercise price of US$7.86 (C$10.87) per Common Share;

•

up to 7,933 Common Shares issuable upon the conversion of the convertible debentures due September 2025 issued by the Company’s wholly-owned subsidiary, The Supreme Cannabis Company, Inc.;

•

up to 6,700,860 Common Shares issuable upon the conversion of the Company’s senior unsecured convertible debentures due May 2029 with a conversion price of C$14.38 per Common Share;

•

up to 1,763,696 Common Shares issuable upon exercise of replacement common share purchase warrants issued to former securityholders of Acreage Holdings, Inc. (“Acreage”) in connection with Canopy USA’s acquisition of Acreage (the “Acreage Acquisition”), with a weighted average exercise price of US$3.66 (C$5.06) per Common Share; and

•

38,094 Common Shares issuable in connection with the acquisition by Canopy USA, LLC (“Canopy USA”) of the minority interests of certain subsidiaries of Acreage.

In addition, the number of Common Shares outstanding does not reflect other future issuances of Common Shares. See “Risk Factors — Risks Related to This Offering — Our shareholders may be subject to dilution resulting from future issuances of Common Shares by us.”

<div align='center'>S-4</div>

TABLE OF CONTENTS

### RISK FACTORS
Investing in our Common Shares involves a high degree of risk. Before deciding whether to invest in our Common Shares, you should consider carefully the risks